Literature DB >> 11390646

Functional characterization of interferon regulatory factor 3a (IRF-3a), an alternative splice isoform of IRF-3.

A Y Karpova1, L V Ronco, P M Howley.   

Abstract

Virus infection of numerous cell types results in the transcriptional induction of a subset of virus- and interferon (IFN)-stimulated genes. The beta IFN (IFN-beta) gene is one of these rapidly induced genes; it serves as a fundamental component of the cellular defense response in eliciting potent antiviral, immunomodulatory, and antiproliferative effects. One of the transcription factors involved in the stringent regulation of IFN-beta production following virus infection is interferon regulatory factor (IRF) 3 (IRF-3). We have characterized an alternatively spliced isoform of IRF-3 that we have called IRF-3a. IRF-3a can selectively and potently inhibit virus-induced activation of the IFN-beta promoter. IRF-3a lacks half of the DNA binding domain found in IRF-3 and is unable to bind to the classical IRF binding elements, IFN-stimulated response elements. These studies suggest that IRF-3a may act as a modulator of IRF-3.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390646      PMCID: PMC87078          DOI: 10.1128/MCB.21.13.4169-4176.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  30 in total

Review 1.  Interferon regulatory factors: the next generation.

Authors:  Y Mamane; C Heylbroeck; P Génin; M Algarté; M J Servant; C LePage; C DeLuca; H Kwon; R Lin; J Hiscott
Journal:  Gene       Date:  1999-09-03       Impact factor: 3.688

2.  Dual utilization of an acceptor/donor splice site governs the alternative splicing of the IRF-3 gene.

Authors:  A Y Karpova; P M Howley; L V Ronco
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

3.  IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency.

Authors:  L Zhang; J S Pagano
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

4.  NF-kappa B: ten years after.

Authors:  P A Baeuerle; D Baltimore
Journal:  Cell       Date:  1996-10-04       Impact factor: 41.582

5.  Multiple mechanisms of transcriptional repression by YY1.

Authors:  K M Galvin; Y Shi
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

6.  Complementation of the radiosensitive M059J cell line.

Authors:  B S Hoppe; R B Jensen; C U Kirchgessner
Journal:  Radiat Res       Date:  2000-02       Impact factor: 2.841

7.  Analysis of functional domains of interferon regulatory factor 7 and its association with IRF-3.

Authors:  W C Au; W S Yeow; P M Pitha
Journal:  Virology       Date:  2001-02-15       Impact factor: 3.616

8.  Phosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domain.

Authors:  I Marié; E Smith; A Prakash; D E Levy
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

9.  Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons.

Authors:  A Meinke; F Barahmand-Pour; S Wöhrl; D Stoiber; T Decker
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

10.  Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation.

Authors:  H Harada; T Kondo; S Ogawa; T Tamura; M Kitagawa; N Tanaka; M S Lamphier; H Hirai; T Taniguchi
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

View more
  24 in total

1.  The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway.

Authors:  Pengyuan Yang; Huazhang An; Xingguang Liu; Mingyue Wen; Yuanyuan Zheng; Yaocheng Rui; Xuetao Cao
Journal:  Nat Immunol       Date:  2010-05-09       Impact factor: 25.606

2.  Genome-wide detection of tissue-specific alternative splicing in the human transcriptome.

Authors:  Qiang Xu; Barmak Modrek; Christopher Lee
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

3.  Characterization of a spliced variant of human IRF-3 promoter and its regulation by the transcription factor Sp1.

Authors:  Wei Ren; Liang-Hua Zhu; Hua-Guo Xu; Rui Jin; Guo-Ping Zhou
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

Review 4.  Post-transcriptional regulation of gene expression in innate immunity.

Authors:  Susan Carpenter; Emiliano P Ricci; Blandine C Mercier; Melissa J Moore; Katherine A Fitzgerald
Journal:  Nat Rev Immunol       Date:  2014-06       Impact factor: 53.106

5.  Interferon regulatory factor 3-CL, an isoform of IRF3, antagonizes activity of IRF3.

Authors:  Chunhua Li; Lixin Ma; Xinwen Chen
Journal:  Cell Mol Immunol       Date:  2010-12-06       Impact factor: 11.530

6.  The characterization of two novel IRF-3 transcripts starting from intron 2 of the wild type of IRF-3.

Authors:  Wei Ren; Hua-Guo Xu; Chao Lu; Rui Jin; Li Zou; Yi Wang; Guo-Ping Zhou
Journal:  Mol Biol Rep       Date:  2010-12-01       Impact factor: 2.316

7.  Transcript specific regulation of expression influences susceptibility to multiple sclerosis.

Authors:  Maria Ban; Wenjia Liao; Amie Baker; Alastair Compston; John Thorpe; Paul Molyneux; Mary Fraser; Jyoti Khadake; Joanne Jones; Alasdair Coles; Stephen Sawcer
Journal:  Eur J Hum Genet       Date:  2020-01-13       Impact factor: 4.246

Review 8.  Post-transcriptional control of the interferon system.

Authors:  Khalid S A Khabar; Howard A Young
Journal:  Biochimie       Date:  2007-02-24       Impact factor: 4.079

9.  Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response.

Authors:  Andrea Paun; Jorgen T Reinert; Zhaozhao Jiang; Carey Medin; Mumtaz Yaseen Balkhi; Katherine A Fitzgerald; Paula M Pitha
Journal:  J Biol Chem       Date:  2008-03-10       Impact factor: 5.157

10.  Impairment of interferon-induced IRF-7 gene expression due to inhibition of ISGF3 formation by trichostatin A.

Authors:  Pierre Génin; Pierre Morin; Ahmet Civas
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.